, we reported on H.R. 2820, the Stem Cell Therapeutic and Research Reauthorization Act of 2015. Here is an update on that legislation.
On December 16, 2015, the bill passed by roll call vote. According to , 421 Congressional members voted for the bill. None opposed it. (There were 12 representatives who didn’t vote.) On Friday, December 18, 2015, President Obama signed the bill into law.
Upon passage, the bill’s sponsor (R-NJ) remarked: “It is incredibly timely to reauthorize this life-giving program during the Christmas season, the gift-giving time of year. It remains one of the best kept secrets in America that umbilical cord blood stem cells and adult stem cells in general are curing people of a myriad of terrible conditions and diseases in adults as well as children.”
“Cord blood, what was once seen as medical waste, is now making miracles. Americans willing to give the gift of life to others are at the heart of the success of this program. In reauthorizing it we are grateful for the adult donors willing to provide bone marrow or peripheral blood stem cells, as well as mothers who donate their child’s cord blood through cord blood banks.”
To get a firsthand look at the extraordinary benefits of cord blood, Smith visited Celgene Corporation in Summit, New Jersey last year to learn about how cord blood is being used to heal diabetic foot ulcers and how its researchers are turning amniotic membrane (an old placenta) into wound management.
As adopted by the House and the Senate, H.R. 2820 now ensures that two related programs that support treatment and therapies derived from adult stem cell lines will continue to receive funding through 2020. The C.W. Bill Young Cell Transplantation Program authorizes expenditures of $30 million annually for five years, while the National Cord Blood Inventory (NCBI) authorizes $23 million annually for the same five year period. Language was added to the bill this time to study “the state of science using adult stem cells and birthing tissues to develop new therapies for patients.”
H.R. 2820 was co-sponsored by Rep. Doris Matsui (D-CA). Other members who were instrumental in its passage include Reps. David Jolly (R-FL) and Chaka Fattah (D-PA) in the House, and Senators Orrin Hatch (R-UT), Jack Reed (R-RI), Richard Burr (R-NC) and Al Franken (D-MN) in the Senate.
The passage of this bill celebrates the miracle that not only do the placenta and umbilical cord nurture the life of an unborn child, they also offer the gift of helping others. As Smith concludes: “Something very special is left behind after birth – cord blood – that’s teeming with lifesaving stem cells.”
Protect your baby’s future and health with banking. Learn more with our free cord blood banking pricing calculator. Call CorCell today at (702) 914-7250 or (888) 882-CORD(2673) – international calls – for more information.